This trial is evaluating whether VID-KIDS Intervention Program will improve 1 primary outcome in patients with Postpartum Depression. Measurement will happen over the course of through study completion, an average of 18 weeks.
This trial requires 100 total participants across 2 different treatment groups
This trial involves 2 different treatments. VID-KIDS Intervention Program is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Depression is the most common medical condition experienced by pregnant mothers after they have delivered their first baby. Postpartum depression is a condition that may occur during pregnancy, labor and after delivery. Postpartum depression is a major risk factor for poor maternal and infant mental health.\n
The prevalence of postpartum depression is about 8%. Women have several possible risk factors: young, educated, a low-income family, and having twins or multiples. They should be counseled about the risks. Preventive efforts are needed to educate and help pregnant women about the risks of postpartum depression. Depression screening for women who are pregnant or who are in the postpartum period is important.
The first-line drugs of choice are paroxetine and venlafaxine, and other medication, such as escitalopram and lisuride, can be used as well. Psychotherapy is the first line treatment, focusing on the emotional component and emotional education. Postpartum, psychotherapy should take into account the maternal anxiety and the baby's cry, which could be dealt with with CBT.
The causes of postpartum depression and the risks of developing it are complex. Although the strongest risk factors occur during pregnancy, there is an increased risk after birth, especially in the first year, even after adjusting for factors thought to contribute to depression. In addition, postpartum depression may development in women who were previously depressed before the baby was born.
In terms of an effective treatment for postpartum depression, no intervention or pharmacotherapy is as effective as cognitive behavioral therapy. Cognitive behavioral training combined with antidepressant medications is the most effective combination treatment.
In women with antenatal depression and postpartum depression, it has been suggested that depression has been asymptomatic, but the current investigation has found that symptomatic depression was observed in some women when measured as late as 12 months postpartum. However, the results of the current study do not show that postpartum depression is asymptomatic. This finding is not entirely consistent with the hypothesis that the cause of late onset postpartum depression is due to a subclinical illness that can only be diagnosed at some later stage of the postpartum period. A systematic review of this issue found the existing data insufficient to support or deny the proposition that postpartum depression has always been the consequence of subclinical depression.
Women who delivered babies have a higher risk of postpartum depression (12 percent and 35 percent respectively) compared to women who delivered babies once. The risk is even higher when both women gave birth once. These rates are comparable with those of women who delivered babies in Western countries. However, these results imply that there are substantial differences with the rates in some developing countries. To increase knowledge about the postpartum depression, further studies are needed.
The prevalence of major depression is relatively high (around 8%) in women who have delivered at least once. These women are at higher risk of serious postpartum depression.
Results from a recent paper provides evidence that Vid-kids may be a useful tool for the treatment of postpartum depression and associated QoL impairment. It may also provide a unique opportunity to develop methods that will allow the treatment of postpartum depression to focus on the specific aspects of QoL that are most impaired.
There is no need for additional staff for vid-kids program compared to the usual care, and patients and their parents showed no difference regarding the satisfaction with treatment and level of knowledge and behavior regarding depression and coping skills.
It is difficult to know the exact causes and causes of maternal postpartum depression because it is difficult to study it without a proper control group. There were no discoveries in treatments for postpartum depression.
Results from a recent paper did not find any effect on the maternal behaviors that were assessed in this trial, but the results still need to be confirmed using a larger experimental design.